More recently, PRMT5 expression was shown to be increased in breast cancer stem cells (BCSCs), and that its knock down reduces proliferation and self‐renewal of BCSCs both in vitro and in vivo.26 This evidence concerns the gene PRMT5 and breast carcinoma.